Open Orphan #ORPH – Notice of Results, Analyst Briefing and Investor Presentation

Open Orphan (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials , announces that its interim results for the six-month period ended 30 June 2021 will be released on Monday, 20 September 2021. Analyst Briefing A briefing open to analysts will […]